NCT01044836View on ClinicalTrials.gov

Safety and Pharmacokinetic Characteristics of HD203 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

August 31, 2010

Conditions
Healthy
Interventions
BIOLOGICAL

HD203

Injectable form

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

Hanwha Chemical
All Listed Sponsors
lead

Hanwha Chemical

INDUSTRY